ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
Categories of resistance: MDR, XDR, PDR, UDR, and (new!) DTR
IDSA White Paper on developing narrow-spectrum antimicrobials + editorial by G. Drusano
Plazomicin (Achaogen) financial post-mortem: #PassPASTEUR
Public meeting on the LPAD Pathway: Post-meeting thoughts (wonkish)
Draft EMA antibacterial guidance: Analysis
De-risking vaccine development: Insights spanning decades of experience
COVID-19 and the Long-Term Trajectory of AMR Efforts: Wellcome Trust Deep Dive
New mechanisms for antibiotic reimbursement in the United States: CMS’s IPPS FY2020 Final Rule
FDA analysis of 40-years of antibacterial development: Dheman et al.
FDA workshop: Insights on inhaled antifungals and antibacterials
Chemical vs. drugs (Part 2): How do you discriminate? / More on halicin
Lessons in Discovery from Lynn Silver + Pro-con on alternatives to antibiotics
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet